Find

Search Newsmax Health Search Newsmax Search Web
Newsletters Video Shop Contact Us Archives
 
Newsmax Newsmax Moneynews Newsmax.TV
 
 
Health Stories  

High Cholesterol Tied to Alzheimer's

Tuesday, September 13, 2011 7:29 AM

Print this Page  

Forward Page  Forward Page

Email Us  Email Us

People who accumulate plaque on their arteries may be more prone to another insidious type of buildup — one that clogs their brains.

Scientists who tested the cholesterol levels of 147 patients found that those with the highest readings were more likely to also have the brain plaque that signals Alzheimer’s disease. The research was published Tuesday in the medical journal Neurology.

The findings suggest that lowering cholesterol levels early in life may reduce the prevalence of Alzheimer’s, a progressive disease that starts with forgetfulness and eventually saps memories and independence. Doctors have struggled to understand, predict, and slow the advance of the illness ever since it was first described by German doctor Alois Alzheimer more than a century ago.

“Our study clearly makes the point that high cholesterol may contribute directly or indirectly to plaques in the brain,” Kensuke Sasaki, the study’s lead author and an associate professor at Kyushu University in Fukuoka, Japan, said in a telephone interview. “The management of cholesterol levels early on may lead to preventing Alzheimer’s disease later.”

Sasaki and his colleagues tested the cholesterol of 2,587 adults aged 40 to 79 in southern Japan 23 years ago and sought permission to autopsy those patients after they died to look for plaques and tangles in the brain that signal Alzheimer’s.

The results, based on the 147 participants who were autopsied, show that 86 percent of those with high cholesterol had brain plaques, compared with 62 percent of those with low cholesterol.

The researchers will continue to gather data, Sasaki said. The study is funded by the Japan Society for the Promotion of Science and the country’s health ministry.

Alzheimer’s disease afflicts about 36 million people worldwide, a number that is expected to double by 2050, according to the Alzheimer’s Association, an advocacy group based in Chicago. Existing drugs temporarily ease symptoms and none cure the condition.

Copyright Bloomberg News

 

 

   
   
   
       Privacy Policy  |  Terms & conditions  |  Contact Us

PLEASE NOTE: All information presented in Newsmaxhealth.com and Newsmax.com is for informational purposes only. It is not specific medical advice for any individual. All answers to reader questions are provided for informational purposes only. All information presented on our websites should not be construed as medical consultation or instruction. You should take no action solely on the basis of this publication’s contents. Readers are advised to consult a health professional about any issue regarding their health and well-being. While the information found on our websites is believed to be sensible and accurate based on the author’s best judgment, readers who fail to seek counsel from appropriate health professionals assume risk of any potential ill effects. The opinions expressed in Newsmaxhealth.com and Newsmax.com do not necessarily reflect those of Newsmax Media. Please note that this advice is generic and not specific to any individual. You should consult with your doctor before undertaking any medical or nutritional course of action